● Recruiting

A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment

Condition: Bacterial Infections · Sponsor: Qpex Biopharma, Inc.

PhasePhase 1

Planned participants40

Who can joinAll sexes, 18 Years to 80 Years

Healthy volunteersYes

About this study

A Phase 1, Open-label, Single-dose Study to Determine the Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam (S-649228) in Participants with Renal Impairment

This description comes directly from the study's public registry record.

Talk to the study team

Grigor Mamikonyan, PharmD,PhD · (954) 404-8068 · gmamikonyan@clinartis.com

Always discuss trial participation with your own doctor first.

Locations (2)

University of Miami Clinical Pharmacology	Miami, Florida, United States	Recruiting
Orlando Clinical Research Center	Orlando, Florida, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07104162